![]() |
![]() |
||||||||||||||||||||
![]() ![]() |
|||||||||||||||||||||
|
|
|||||||||||||||||||||
|
The Oxford-Durham Trial DRT supported research
has
demonstrated that many children with dyslexia, developmental
coordination
disorder (dyspraxia) or attention deficit hyperactivity disorder
(ADHD),
or
combinations of these can benefit hugely from taking omega-3 fish oil supplements.
These
provide the highly unsaturated fatty acids (HUFAs) that make up one fifth (20%) of
the
weight of the brain. One of these, eicosapentanoic acid (EPA), may
be
particularly important for sharp brain function because magnocellular
neurones
seem to be especially vulnerable to EPA deficiency. But few people eat
enough
oily fish nowadays. Recently the results of our Oxford-Durham
study were
published showing that 3 months' supplemental fish oil capsules can
help the
reading, spelling, attention and concentration of children with
dyspraxia to
improve very
significantly (Pediatrics 2005, 115(5):
1360-66). Furthermore we have noticed remarkable improvements in
many of
the children attending our DRT clinics after we have recommended
they take EPA fish oil
supplements. These are being quantified at the moment. Such improvements don’t
only apply
to children however. People often worry that once a person becomes
an
adult their brain structure is fixed. But the brain is continuously
adapting
and HUFAs move in and out of nerve membranes quite fast. Any losses
must
therefore be provided by the diet, because the body cannot manufacture
them by
itself. So there is much anecdotal evidence that EPA supplements can
also help
adults. Supported by the charity, Natural Justice, which was set up by
the late
Bishop Hugh Montefiore, Bernard Gesch who has recently joined us,
was able to show that simply adding fish oils, minerals and vitamins to
the
diets of young offenders can reduce their rates of offending and
violence by an amazing
one
third (British Journal of Psychiatry (2002) 181, 22-8). Also Alex Richardson is now conducting a controlled treatment trial of adding fish oil supplements to the diet of adult dyslexics. This should enable us to identify the individuals who might benefit most from the supplements and hopefully explain the great improvements, particularly in attention and concentration, that they often demonstrate. The trial is 'double-blind' and 'placebo controlled', which means that neither the researchers, nor the subjects, know who is getting the placebo and who is getting the fish oil. Indeed, that won’t be disclosed until after the analysis has been done, to rule out the possibility of introducing bias when the results are looked at. “The fish oils have been reported by so many people to have helped their children”, says Annie Shrier who's helping with this research, “that we're really bursting to know if they can benefit adults as well. If so, this would represent a real breakthrough for all the adult dyslexics who have struggled through life, probably under-performing. They would no longer feel as though they had missed the boat as far as remedial measures are concerned”. Running alongside this study, the team are also looking to see if there is a relationship between visual problems often seen in dyslexia, and their level of essential fatty acids. |
|
|||||||||||||||||||
|
|
|
|
|||||||||||||||||||
| News | |||||||||||||||||||||
|
|
|
|
|||||||||||||||||||